1. Alarcon E, Bissell K, Boillot F, Caminero JA, Chiang C, Clevenbergh P, et al. Isoniazid preventive therapy for people living with HIV : public health challenges and implementation issues. Int J Tuberc Lung Dis. 2015;13(8):927–35.
2. Makanjuola T, Taddese HB, Booth A. Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data. PLoS ONE. 2014;9(2):e87166.
3. Getachew Y, Mekonnen W. Correlates of adherence and utilization of Isoniazid preventive therapy in HIV patients. J Microbiol Infect Dis. 2015;5:45–50.
4. Isoniazid Preventive Therapy (IPT) for the Prevention of Tuberculosis in People Living with HIV (e-course)|FHI 360. https://www.fhi360.org/resource/isoniazid-preventive-therapy-ipt-prevention-tuberculosis-people-living-hiv-e-course.
5. Hiransuthikul N, Hiransuthikul P, Nelson KE, Jirawisit M, Paewplot R, Kasak S, et al. Physician adherence to isoniazid preventive therapy guidelines for HIV infected patients in Thailand. Southeast Asian J Trop Med Public Heal. 2005;36(5):1208–15.